These protein kinases otherwise act to constrain deleterious overexpression of particular genes (e.g., IL6), and even that of cancer p53 mutants (deletion in exon-5) and isoforms of chemokine ligands via downstream transcription factors [75,76,77,78,79]. This evidence concerns the gene WEE1 and cancer.